Literature DB >> 24388982

Identification of prohibitin and prohibiton as novel factors binding to the p53 induced gene 3 (PIG3) promoter (TGYCC)(15) motif.

Xiaoxiang Guan1, Zhensheng Liu2, Luo Wang3, David G Johnson4, Qingyi Wei5.   

Abstract

The promoter of p53 induced gene 3 (PIG3) contains a variable number of tandem repeats (VNTRs) of pentanucleotides (TGYCC)n that is known as a p53 binding site. In this study, we investigated whether other potential molecules could bind to this PIG3 promoter (TGYCC)n motif. Ligand-chromatography combined with liquid chromatography-tandem mass spectrometry analyses indicated direct interactions of prohibitin and/or prohibiton with the (TGYCC)15 motif, which was confirmed by electrophoretic mobility shift assay and super-gel shift analysis with anti-prohibitin and anti-prohibiton antibodies. Using the chromatin immunopercipipation assay, we further demonstrated that prohibitin and prohibiton associated with the (TGYCC)15 motif in vivo regardless of the p53 status and apoptotic stress. We also found that prohibitin and prohibiton up-regulated PIG3 transcription independent of p53, although p53 obviously enhanced this process, and that the knock-down of prohibitin and prohibiton inhibited camptothecin-induced apoptosis. Taken together, our findings suggest that prohibitin and prohibiton contribute to PIG3-mediated apoptosis by binding to the PIG3 promoter (TGYCC)15 motif.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  (TGYCC)n motif; PIG3; Prohibitin; Prohibiton

Mesh:

Substances:

Year:  2014        PMID: 24388982      PMCID: PMC4155496          DOI: 10.1016/j.bbrc.2013.12.124

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  19 in total

1.  A functional variant at the miR-184 binding site in TNFAIP2 and risk of squamous cell carcinoma of the head and neck.

Authors:  Zhensheng Liu; Sheng Wei; Hongxia Ma; Mei Zhao; Jeffrey N Myers; Randal S Weber; Erich M Sturgis; Qingyi Wei
Journal:  Carcinogenesis       Date:  2011-09-20       Impact factor: 4.944

2.  The prohibitin family of mitochondrial proteins regulate replicative lifespan.

Authors:  P J Coates; D J Jamieson; K Smart; A R Prescott; P A Hall
Journal:  Curr Biol       Date:  1997-08-01       Impact factor: 10.834

3.  Association of the PIG3 promoter polymorphism with invasive bladder cancer in a Japanese population.

Authors:  Masaaki Ito; Hiroyuki Nishiyama; Jun Watanabe; Hiroaki Kawanishi; Takeshi Takahashi; Toshiyuki Kamoto; Tomonori Habuchi; Osamu Ogawa
Journal:  Jpn J Clin Oncol       Date:  2006-01-17       Impact factor: 3.019

4.  Prohibitins regulate membrane protein degradation by the m-AAA protease in mitochondria.

Authors:  G Steglich; W Neupert; T Langer
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

Review 5.  Prohibitin: a potential target for new therapeutics.

Authors:  Suresh Mishra; Leigh C Murphy; B L Gregoire Nyomba; Liam J Murphy
Journal:  Trends Mol Med       Date:  2005-04       Impact factor: 11.951

6.  Absence of association with cancer risk and low frequency of alterations at a p53 responsive PIG3 gene polymorphism in breast and lung carcinomas.

Authors:  V G Gorgoulis; T Liloglou; F Sigala; D Korkolis; D Yannoukakos; E Papalambros; P J Asimacopoulos; A G Papavassiliou; A Kotsinas
Journal:  Mutat Res       Date:  2004-11-22       Impact factor: 2.433

Review 7.  PIG3: a novel link between oxidative stress and DNA damage response in cancer.

Authors:  Athanassios Kotsinas; Vimla Aggarwal; E-Jean Tan; Brynn Levy; Vassilis G Gorgoulis
Journal:  Cancer Lett       Date:  2011-12-14       Impact factor: 8.679

8.  Functional repeats (TGYCC)n in the p53-inducible gene 3 (PIG3) promoter and susceptibility to squamous cell carcinoma of the head and neck.

Authors:  Xiaoxiang Guan; Zhensheng Liu; Luo Wang; Li-E Wang; Erich M Sturgis; Qingyi Wei
Journal:  Carcinogenesis       Date:  2012-12-14       Impact factor: 4.944

9.  Cell cycle activity and expression of prohibitin mRNA.

Authors:  A J Roskams; V Friedman; C M Wood; L Walker; G A Owens; D A Stewart; M S Altus; D B Danner; X T Liu; J K McClung
Journal:  J Cell Physiol       Date:  1993-11       Impact factor: 6.384

10.  Prohibitin, an antiproliferative protein, is localized to mitochondria.

Authors:  E Ikonen; K Fiedler; R G Parton; K Simons
Journal:  FEBS Lett       Date:  1995-01-30       Impact factor: 4.124

View more
  11 in total

1.  The Synthetic Small Molecule FL3 Combats Intestinal Tumorigenesis via Axin1-Mediated Inhibition of Wnt/β-Catenin Signaling.

Authors:  Dakota N Jackson; Kibrom M Alula; Yaritza Delgado-Deida; Redouane Tabti; Kevin Turner; Xuan Wang; K Venuprasad; Rhonda F Souza; Laurent Désaubry; Arianne L Theiss
Journal:  Cancer Res       Date:  2020-07-14       Impact factor: 12.701

2.  Skp2 is over-expressed in breast cancer and promotes breast cancer cell proliferation.

Authors:  Wenwen Zhang; Lulu Cao; Zijia Sun; Jing Xu; Lin Tang; Weiwei Chen; Jiayan Luo; Fang Yang; Yucai Wang; Xiaoxiang Guan
Journal:  Cell Cycle       Date:  2016-04-25       Impact factor: 4.534

Review 3.  Prohibitin ligands: a growing armamentarium to tackle cancers, osteoporosis, inflammatory, cardiac and neurological diseases.

Authors:  Dong Wang; Redouane Tabti; Sabria Elderwish; Hussein Abou-Hamdan; Amel Djehal; Peng Yu; Hajime Yurugi; Krishnaraj Rajalingam; Canan G Nebigil; Laurent Désaubry
Journal:  Cell Mol Life Sci       Date:  2020-02-15       Impact factor: 9.261

4.  The mitochondrial chaperone Prohibitin 1 negatively regulates interleukin-8 in human liver cancers.

Authors:  Jin Won Yang; Ben Murray; Lucia Barbier-Torres; Ting Liu; Zhenqiu Liu; Heping Yang; Wei Fan; Jiaohong Wang; Yuan Li; Ekihiro Seki; José M Mato; Shelly C Lu
Journal:  J Biol Chem       Date:  2018-12-06       Impact factor: 5.157

Review 5.  Multifaceted role of prohibitin in cell survival and apoptosis.

Authors:  Ya-Ting Peng; Ping Chen; Ruo-Yun Ouyang; Lei Song
Journal:  Apoptosis       Date:  2015-09       Impact factor: 4.677

6.  BRCA1 regulates PIG3-mediated apoptosis in a p53-dependent manner.

Authors:  Wenwen Zhang; Jiayan Luo; Fengxia Chen; Fang Yang; Wei Song; Aiyu Zhu; Xiaoxiang Guan
Journal:  Oncotarget       Date:  2015-04-10

Review 7.  Significance of prohibitin domain family in tumorigenesis and its implication in cancer diagnosis and treatment.

Authors:  Jie Yang; Bin Li; Qing-Yu He
Journal:  Cell Death Dis       Date:  2018-05-21       Impact factor: 8.469

8.  Identification of HeLa cell proteins that interact with Chlamydia trachomatis glycogen synthase using yeast two‑hybrid assays.

Authors:  Zhenjie Sun; Yuhui Sun; Yumeng Li; Xiuli Luan; Hui Chen; Haiying Wu; Bo Peng; Chunxue Lu
Journal:  Mol Med Rep       Date:  2020-01-16       Impact factor: 2.952

Review 9.  SFPH proteins as therapeutic targets for a myriad of diseases.

Authors:  Dong Wang; Redouane Tabti; Sabria Elderwish; Amel Djehal; Nora Chouha; Franck Pinot; Peng Yu; Canan G Nebigil; Laurent Désaubry
Journal:  Bioorg Med Chem Lett       Date:  2020-10-06       Impact factor: 2.823

10.  p53-inducible gene 3 promotes cell migration and invasion by activating the FAK/Src pathway in lung adenocarcinoma.

Authors:  Meng-Meng Gu; Dexuan Gao; Ping-An Yao; Lan Yu; Xiao-Dong Yang; Chun-Gen Xing; Jundong Zhou; Zeng-Fu Shang; Ming Li
Journal:  Cancer Sci       Date:  2018-10-26       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.